Ziccum
Business Services · 11-50 Employees
View Company Info for Free
Overview
Phone Number
+46 709615599Website
www.ziccum.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Ziccum
Ziccum specializes in the development of LaminarPace, a unique mass transfer drying technology that transforms delicate biopharmaceuticals and vaccines into thermostable, particle-engineered dry powders. This innovative method eliminates heat stress and degradation, making it ideal for next-generation biologics and mRNA therapeutics. The company targets high-value vaccine platforms and offers licensing and tech transfer opportunities to pharmaceutical companies. Ziccum aims to enhance the stability and usability of biotherapeutics while facilitating sustainable production methods.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Ziccum your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Ziccum had a recent Job posting/layoffs
Check if Ziccum has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Ziccum
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Ziccum has new funding data
Check out if Ziccum is spiking on competitors!
Ziccum, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Ziccum recently announced quarterly report
Product Launch: Get notified when Ziccum launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Ziccum is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Ziccum is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Ziccum.
Ziccum Tech Stack
A closer look at the technologies used by Ziccum
Most Recent Scoops
Pain Point
Pain Point, Bankruptcy, Finance
New Hire
Executive Move
Executive Moves
Left Company
Executive Move
Executive Moves
Open Position
Executive Move
New Hire
Executive Move
Executive Moves
Ziccum News & Media
Ziccum appoints senior biopharma executive as new CFO | MarketScreener
Ziccum AB has appointed Johny Humaloja as its new CFO. Johny is a financial executive with decades of experience in the biopharma and biotech industries in Europe and the US. He will assume his new... | June 2, 2023ZICCUM AB appoints Ann Gidner as new CEO – 'outstanding record in business ... - Market Screener
Ann Gidner takes office as new CEO of Ziccum AB on May 9, 2022. Ann has extensive CEO and Business Development experience, driving growth in a wide range of early-stage life science companies. In a... | March 28, 2022Ziccum AB carries out list change to Nasdaq First North Growth Market and releases company description
Ziccum AB (“Ziccum” or “the Company”) announces today, November 11, 2020, that it has received approval for admission to trade on the Nasdaq First North Growth Market. The first day of trading on the Nasdaq First North Growth Market will be December 1, 2020. Trading in the Company's share on the Spotlight Stock Market will cease and the last day for trading on the Spotlight Stock Market will be November 30, 2020. Nasdaq's decision isZICCUM AB releases blueprint of world’s first industrial plant producing air-dried vaccines requiring no Cold Chain
“Vaccinating the world against COVID-19 will be one of the largest mass undertakings in human history” - as UNICEF, the WHO, analysts, NGOs and governments worldwide warn of the escalating challenge the Cold Chain represents to vaccine coverage in both the developed and developing world, Swedish vaccine formulation company Ziccum releases its blueprint of the world’s first industrial plant for producing thermostable, ambient-dried vaccines at volume. The new vaccines could be produced at an esti
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Ziccum
Sign Up For FreeTo access detailed company insights
Ziccum specializes in the development of LaminarPace, a unique mass transfer drying technology that transforms delicate biopharmaceuticals and vaccines into thermostable, particle-engineered dry powders. This innovative method eliminates heat stress and degradation, making it ideal for next-generation biologics and mRNA therapeutics. The company ta... Read More
